Elevation Oncology (ELEV) Insider Trading & Ownership

$3.28
-0.23 (-6.55%)
(As of 05/10/2024 ET)

Elevation Oncology (NASDAQ:ELEV) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
14.90%
Number Of
Insiders Buying
(Last 3 Years)
0
Number Of
Insiders Selling
(Last 3 Years)
1
Amount Of
Insider Selling
(Last 3 Years)
$2.90 M
Get ELEV Insider Trade Alerts

Want to know when executives and insiders are buying or selling Elevation Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ELEV Insider Buying and Selling by Quarter

Elevation Oncology Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/25/2022Global Strategic Fund I VenbioMajor ShareholderSell702,737$4.12$2,895,276.44  
(Data available from 1/1/2013 forward)

ELEV Insider Trading Activity - Frequently Asked Questions

Who is on Elevation Oncology's Insider Roster?

The list of insiders at Elevation Oncology includes Global Strategic Fund I Venbio. Learn more on insiders at ELEV.

What percentage of Elevation Oncology stock is owned by insiders?

14.90% of Elevation Oncology stock is owned by insiders. Learn more on ELEV's insider holdings.

Which Elevation Oncology insiders have been selling company stock?

The following insider sold ELEV shares in the last 24 months: Global Strategic Fund I Venbio ($2,895,276.44).

How much insider selling is happening at Elevation Oncology?

Insiders have sold a total of 702,737 Elevation Oncology shares in the last 24 months for a total of $2,895,276.44 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:ELEV) was last updated on 5/11/2024 by MarketBeat.com Staff

From Our Partners